We observed TNNT2 positive staining regardless of presence (+) or absence (-) of cardiovascular comorbidities (CVM): TNNT2(-)/CVM(-), 13; TNNT2(-)/CVM(+), 30; TNNT2(+)/CVM(-), 14; TNNT2(+)/CVM(+), 11 in 68 cancer patients. The gene discussed is TNNT2; the disease is cancer.